Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine …
A Asatryan, N Meyer, M Scherbakov… - Human Vaccines & …, 2021 - Taylor & Francis
As vaccine-induced immunity and protection following natural pertussis infection wane over
time, adults and adolescents may develop pertussis and become transmitters to unprotected …
time, adults and adolescents may develop pertussis and become transmitters to unprotected …
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
P Van Damme, P McIntyre, E Grimprel, S Kuriyakose… - Vaccine, 2011 - Elsevier
BACKGROUND: Older adults, especially those over 65 years, are at risk of more severe
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …
[HTML][HTML] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria …
D Brandon, M Kimmel, SO Kuriyakose, L Kostanyan… - Vaccine, 2018 - Elsevier
Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …
among adults, despite being a vaccine-preventable disease. Methods This phase III …
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults
J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
Seroprevalence of antibodies against diphtheria, tetanus and pertussis in adult at-risk patients
L Boey, E Bosmans, LB Ferreira, N Heyvaert, M Nelen… - Vaccines, 2021 - mdpi.com
Patients with chronic diseases are at increased risk of complications following infection. It
remains, however, unknown to what extend they are protected against vaccine-preventable …
remains, however, unknown to what extend they are protected against vaccine-preventable …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular …
T Vesikari, SA Silfverdal, F Boisnard… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
Low seroprevalance of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination
MD Tanriover, C Soyler, S Ascioglu… - European journal of …, 2014 - Elsevier
Background Tetanus, diphtheria, pertussis and measles are vaccine preventable diseases
that have been reported to cause morbidity and mortality in adult population in the recent …
that have been reported to cause morbidity and mortality in adult population in the recent …
[HTML][HTML] A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria …
R Marlow, S Kuriyakose, N Mesaros, HH Han… - Vaccine, 2018 - Elsevier
Aim To evaluate the immunogenicity and safety of a reduced antigen diphtheria-tetanus-
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …